+Compare
PRE
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
58.41M

PRE Prenetics Global Limited Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PRE with price predictions
07:00 PM EST Nov 27, 2023

Momentum Indicator for PRE turns negative, indicating new downward trend

PRE saw its Momentum Indicator move below the 0 level on November 17, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator turned negative. In of the 33 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PRE entered a downward trend on November 27, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PRE's RSI Indicator exited the oversold zone, of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 19 cases where PRE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRE just turned positive on November 09, 2023. Looking at past instances where PRE's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRE advanced for three days, in of 48 cases, the price rose further within the following month. The odds of a continued upward trend are .

PRE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.260) is normal, around the industry mean (25.167). P/E Ratio (1.117) is within average values for comparable stocks, (79.649). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.240). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.170) is also within normal values, averaging (45.457).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 3%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 703%. ICCM experienced the highest price growth at 85%, while SLDX experienced the biggest fall at -83%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 47%. For the same stocks of the Industry, the average monthly volume growth was 49% and the average quarterly volume growth was 79%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

PRE is expected to report earnings to fall 37.50% to -5 cents per share on March 12

Prenetics Global Limited PRE Stock Earnings Reports
Q4'23
Est.
$-0.05
Q3'23
Beat
by $0.37
Q2'23
Beat
by $0.01
Q1'23
Missed
by $0.01
Q4'22
Beat
by $0.17
The last earnings report on November 20 showed earnings per share of -7 cents, beating the estimate of -44 cents. With 2.23K shares outstanding, the current market capitalization sits at 58.41M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Unit 701-706, K11 Atelier King’s Road
Phone
+852 22109588
Employees
400
Web
https://www.prenetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURLF3.770.12
+3.29%
Curaleaf Hldgs Inc.
VSTA4.170.07
+1.71%
Vasta Platform Limited
SPRB1.40N/A
N/A
Spruce Biosciences
ADRNY29.08-0.08
-0.27%
Koninklijke Ahold Delhaize N.V.
SMNEY11.41-0.32
-2.73%
Siemens Energy AG

PRE and

Correlation & Price change

A.I.dvisor tells us that PRE and EMBC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRE and EMBC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRE
1D Price
Change %
PRE100%
-8.02%
EMBC - PRE
25%
Poorly correlated
+0.75%
SHC - PRE
22%
Poorly correlated
-0.58%
AORT - PRE
21%
Poorly correlated
-1.77%
IDXX - PRE
21%
Poorly correlated
-1.84%
BLCO - PRE
18%
Poorly correlated
-2.24%
More

Groups containing PRE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRE
1D Price
Change %
PRE100%
-8.02%
Medical Specialties
(undefined stocks)
12%
Poorly correlated
+1.11%
Medical Specialties
(undefined stocks)
12%
Poorly correlated
+1.11%